Nosip is a potential therapeutic target in hepatocellular carcinoma cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Nitric oxide synthase-interacting protein (Nosip) regulates nitric oxide (NO) synthesis and release, impacting physiological and pathological processes.
• The specific role of Nosip in hepatocellular carcinoma (HCC) remains largely uncharacterized.
• Understanding Nosip's function is crucial for developing novel HCC therapeutic strategies.

Purpose of the Study:

• To investigate the role of Nosip in the development and progression of hepatocellular carcinoma (HCC).
• To explore the potential of the natural compound quercetin as an anticancer agent targeting Nosip in HCC.

Main Methods:

• Analysis of Nosip expression levels in HCC tissues and cell lines.
• Utilizing Nosip siRNA to inhibit gene expression and assess effects on HCC cell behavior.
• Overexpression of Nosip to evaluate its impact on HCC cell proliferation, migration, invasion, and apoptosis.
• Investigating the effect of quercetin on HCC cell proliferation and motility, and its correlation with Nosip expression.

Main Results:

• Nosip expression was significantly elevated in HCC tissues and cells compared to normal controls.
• Nosip siRNA transfection suppressed HCC cell proliferation and motility while inducing apoptosis.
• Conversely, Nosip overexpression enhanced HCC cell proliferation, migration, and invasion, and inhibited apoptosis.
• Quercetin demonstrated inhibitory effects on HCC cell proliferation and motility, likely through repressing Nosip expression.

Conclusions:

• Nosip functions as an oncogene, promoting the progression of hepatocellular carcinoma.
• Quercetin exhibits potential as a natural therapeutic compound for HCC by downregulating Nosip expression.